bio statement section 232 pharmaceutical proclamation
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (...
Source route
Continue on bio.org
Leave the platform to read the original full article on the publisher site.
Source: BIO (Biotechnology Innovation Org)
Scope: Industry
Related coverage
More related coverage
SwiftPharma Expands R&D Footprint to Leuven in Strategic Co-Location with Benno Therapeutics
A dynamic, member-driven organisation dedicated to fostering innovation and growth in the life scien...